We are live on ! Find out more
JAM

JW Asset Management Portfolio holdings

AUM $244M
1-Year Est. Return 71.51%
This Fund
S&P 500
This Quarter Est. Return
+6.01%
1 Year Est. Return
+71.51%
3 Year Est. Return
+125.61%
5 Year Est. Return
+131.61%
10 Year Est. Return
+2,490.27%
AUM
$133M
AUM Growth
–
Cap. Flow
+$130M
Cap. Flow %
97.44%
Top 10 Hldgs %
71.03%
Holding
57
New
57
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
TARO
Taro Pharmaceutical Industries Ltd.
TARO
+$15.7M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$14.3M
3
TSLA icon
Tesla
TSLA
+$12.9M
4
AGN
Allergan plc
AGN
+$8.63M
5
BX icon
Blackstone
BX
+$8.48M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 73.88%
2 Consumer Discretionary 14.07%
3 Financials 6.75%
4 Communication Services 0.35%
5 Technology 0.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TLGT
26
DELISTED
Teligent, Inc
TLGT
$1M 0.75%
+11,374
New +$1.07M
VNDA icon
27
Vanda Pharmaceuticals
VNDA
$304M
$971K 0.73%
+67,746
New +$802K
SHPG
28
DELISTED
Shire pic
SHPG
$887K 0.67%
+4,172
New +$885K
ENDP
29
DELISTED
Endo International plc
ENDP
$865K 0.65%
+11,998
New +$822K
IPXL
30
DELISTED
Impax Laboratories, Inc.
IPXL
$825K 0.62%
+26,034
New +$762K
CPRI icon
31
Capri Holdings
CPRI
$1.82B
$714K 0.54%
+9,510
New +$709K
NFLX icon
32
Netflix
NFLX
$307B
$470K 0.35%
+96,390
New +$518K
STRR
33
DELISTED
Star Equity Holdings
STRR
$447K 0.34%
+2,049
New +$403K
AGN
34
DELISTED
Allergan Inc
AGN
$432K 0.32%
+2,032
New +$404K
BKNG icon
35
Booking.com
BKNG
$156B
$342K 0.26%
+7,500
New +$339K
TVTX icon
36
Travere Therapeutics
TVTX
$5.17B
$202K 0.15%
+16,459
New +$170K
BABA icon
37
Alibaba
BABA
$276B
$158K 0.12%
+1,524
New +$156K
PGNX
38
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$156K 0.12%
+20,540
New +$123K
CCLD icon
39
CareCloud
CCLD
$103M
$149K 0.11%
+63,667
New +$192K
ARIA
40
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$148K 0.11%
+21,612
New +$135K
CTIC
41
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$123K 0.09%
+5,227
New +$121K
POZN
42
DELISTED
POZEN INC
POZN
$117K 0.09%
+14,653
New +$126K
WATT icon
43
Energous
WATT
$71.8M
$110K 0.08%
+17
New +$95.2K
ATRS
44
DELISTED
Antares Pharma, Inc.
ATRS
$108K 0.08%
+41,936
New +$94.2K
GERN icon
45
Geron
GERN
$898M
$98K 0.07%
+30,000
New +$83K
SRPT icon
46
Sarepta Therapeutics
SRPT
$1.64B
$87K 0.07%
+6,000
New +$102K
VANI icon
47
Vivani Medical
VANI
$109M
$87K 0.07%
+354
New +$123K
ICPT
48
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$81K 0.06%
+522
New +$96.4K
IDXG
49
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$51K 0.04%
+282
New +$50.2K
CBM
50
DELISTED
Cambrex Corporation
CBM
$51K 0.04%
+2,324
New +$49.3K
1
2
3

Similar funds

SC
Schulhoff & Co Cincinnati, Ohio $243M AUM 17.47% 1-Year Est. Return
HCM
Hutner Capital Management Manchester, Vermont $243M AUM 10.01% 1-Year Est. Return
SC
Solstein Capital Menlo Park, California $244M AUM 29.05% 1-Year Est. Return
HBS
Howard Bailey Securities Fort Wayne, Indiana $243M AUM 13.36% 1-Year Est. Return
GIM
GE Investment Management Norwalk, Connecticut $244M AUM 41.62% 1-Year Est. Return
IFO
Independent Family Office Albany, New York $243M AUM 21.81% 1-Year Est. Return
VG
Visualize Group New York $243M AUM 6.21% 1-Year Est. Return
CP
Creekside Partners Petaluma, California $243M AUM 20.23% 1-Year Est. Return

JW Asset Management's Q4 2014 Portfolio in Review

Q4 2014 is the first quarter with a 13F filing on record for JW Asset Management, which disclosed 57 positions worth $133M. Its ten largest holdings account for 71% of the portfolio.

Its largest position is Taro Pharmaceutical Industries Ltd.: 106,931 shares worth $15.8M.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, followed by Consumer Discretionary and Financials.

  • JW Asset Management's largest Q4 2014 buy was Taro Pharmaceutical Industries Ltd.: 106,931 shares worth $15.8M.
  • JW Asset Management's ten largest holdings make up 71% of its $133M portfolio in Q4 2014.
  • JW Asset Management disclosed 57 positions in Q4 2014, its first 13F filing on record.

Based on JW Asset Management's 13F filing for Q4 2014, filed 5 Feb 2015.